Dysfunctional uterine bleeding. Clarifying its definition, mechanisms, and management

Area of Science:

• Gynecology
• Reproductive Endocrinology

Background:

• The term "dysfunctional uterine bleeding" is often misused as a generic descriptor for abnormal uterine bleeding.
• It specifically denotes bleeding arising from an ovarian endocrinopathy, involving hormonal imbalances.
• Two primary mechanisms are implicated: estrogen withdrawal and sustained estrogen production.

Purpose of the Study:

• To clarify the precise definition and underlying mechanisms of dysfunctional uterine bleeding.
• To outline appropriate treatment strategies based on the specific bleeding mechanism.
• To highlight contraindications for estrogen therapy in managing dysfunctional uterine bleeding.

Main Methods:

• Review of existing literature and clinical guidelines on uterine bleeding.
• Analysis of the hormonal mechanisms (estrogen withdrawal, sustained production) causing dysfunctional uterine bleeding.
• Evaluation of treatment outcomes for progestin and estrogen therapies in anovulatory bleeding.

Main Results:

• Dysfunctional uterine bleeding is exclusively linked to ovarian hormonal dysfunction.
• Estrogen breakthrough bleeding, often seen in chronic anovulation, results from sustained estrogen production.
• Treatment efficacy differs based on the bleeding type; progestin is recommended for anovulatory bleeding.

Conclusions:

• Dysfunctional uterine bleeding is a specific diagnosis related to ovarian endocrinopathy.
• Progestin therapy is the primary treatment for anovulatory bleeding.
• Estrogen therapy is generally contraindicated due to increased risk of endometrial hyperplasia and cancer, except in severe, refractory cases.